Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John A Wagner

Showing results (11-20 of 194) with videos related to

Pageof 20
Sort By:
Biomarkers in Medicine|December 8, 2010
Applications of 'decisionable' biomarkers in cardiovascular drug developmentRajesh Krishna, John A Wagner
Journal of Cellular Physiology|September 14, 2010
Retinoids regulate stem cell differentiationLorraine J Gudas, John A Wagner
The AAPS Journal|August 8, 2008
Accelerating drug development using biomarkers: a case study with sitagliptin, a novel DPP4 inhibitor for type 2 diabetesRajesh Krishna, Gary Herman, John A Wagner
The Journal of Investigative Dermatology|May 15, 2007
CGRP, PACAP, and VIP modulate Langerhans cell function by inhibiting NF-kappaB activationWanhong Ding, John A Wagner, Richard D Granstein
FASEB Bioadvances|November 11, 2021
The nervous system: Orchestra conductor in cancer, regeneration, inflammation and immunityHubert Hondermarck, Pearl S Huang, John A Wagner
Clinical and Translational Science|January 27, 2026
Pharmacokinetics as a BiomarkerJohn A Wagner, Sonal Singh, Zachary L Taylor
Clinical Pharmacology and Therapeutics|December 6, 2017
Wearable Devices in Clinical Trials: Hype and HypothesisElena S Izmailova, John A Wagner, Eric D Perakslis
Clinical and Translational Science|April 9, 2021
COVID-19 vaccines and treatments: When speed is necessary and not enoughThaddeus H Grasela, David A Price, John A Wagner
The Journal of Investigative Dermatology|January 18, 2006
ATPgammaS enhances the production of inflammatory mediators by a human dermal endothelial cell line via purinergic receptor signalingKristina Seiffert, W Ding, John A Wagner, et al.
The AAPS Journal|September 19, 2009
Evaluation of agile designs in first-in-human (FIH) trials--a simulation studyItay Perlstein, James A Bolognese, Rajesh Krishna, et al.
Pageof 20

Showing results (11-20 of 194) with videos related to

Sort By:
Pageof 20
Biomarkers in Medicine|December 8, 2010
Applications of 'decisionable' biomarkers in cardiovascular drug developmentRajesh Krishna, John A Wagner
Journal of Cellular Physiology|September 14, 2010
Retinoids regulate stem cell differentiationLorraine J Gudas, John A Wagner
The AAPS Journal|August 8, 2008
Accelerating drug development using biomarkers: a case study with sitagliptin, a novel DPP4 inhibitor for type 2 diabetesRajesh Krishna, Gary Herman, John A Wagner
The Journal of Investigative Dermatology|May 15, 2007
CGRP, PACAP, and VIP modulate Langerhans cell function by inhibiting NF-kappaB activationWanhong Ding, John A Wagner, Richard D Granstein
FASEB Bioadvances|November 11, 2021
The nervous system: Orchestra conductor in cancer, regeneration, inflammation and immunityHubert Hondermarck, Pearl S Huang, John A Wagner
Clinical and Translational Science|January 27, 2026
Pharmacokinetics as a BiomarkerJohn A Wagner, Sonal Singh, Zachary L Taylor
Clinical Pharmacology and Therapeutics|December 6, 2017
Wearable Devices in Clinical Trials: Hype and HypothesisElena S Izmailova, John A Wagner, Eric D Perakslis
Clinical and Translational Science|April 9, 2021
COVID-19 vaccines and treatments: When speed is necessary and not enoughThaddeus H Grasela, David A Price, John A Wagner
The Journal of Investigative Dermatology|January 18, 2006
ATPgammaS enhances the production of inflammatory mediators by a human dermal endothelial cell line via purinergic receptor signalingKristina Seiffert, W Ding, John A Wagner, et al.
The AAPS Journal|September 19, 2009
Evaluation of agile designs in first-in-human (FIH) trials--a simulation studyItay Perlstein, James A Bolognese, Rajesh Krishna, et al.
Pageof 20